Aiming to establish a regulatory/protective role for SEMA3A in SLE, serum SEMA3A was assessed in patients with SLE, and this level was compared with SLE disease activity [66], where serum SEMA3A levels were lower in SLE patients compared to those in normal controls. The gene discussed is SEMA3A; the disease is systemic lupus erythematosus.